Stimulation with live dengue virus of peripheral blood mononuclear cells from a dengue virus type 4-immune donor generated virus-specific, serotype-cross-reactive, CD8+, class I-restricted cytotoxic T lymphocytes (CTL) capable of lysing dengue virus-infected cells and cells pulsed with dengue virus antigens of all four serotypes. These CTL lysed autologous fibroblasts infected with vaccinia virus-dengue virus recombinant viruses containing the E gene or several nonstructural dengue virus type 4 genes. These results demonstrate that both dengue virus structural and nonstructural proteins are targets for the cytotoxic T-cell-mediated immune response to dengue virus and suggest that serotype-cross-reactive CD8+ CTL may be important mediators of viral clearance and of virus-induced immunopathology during secondary dengue virus infections.
The severe manifestations of dengue virus infections, hemorrhage and shock, are most often seen after secondary infection with a heterologous serotype of dengue virus, implying a central role for the immune response in the pathogenesis of dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Serotype-cross-reactive antibodies at subneutralizing concentrations form complexes with virions which bind to monocytes via Fc receptors, resulting in greater numbers of infected monocytes and high virus titers in vitro (14, 15) . This phenomenon, known as immune enhancement, probably contributes to the pathogenesis of DHF-DSS but may be only part of the overall process. Less is known about the T-cell responses to dengue virus and its role in the immunity to and pathogenesis of DHF-DSS.
We have shown that CD4+ T cells from dengue virusimmune humans and mice proliferate in response to soluble dengue virus antigens (22, 27) . They produce gamma interferon (IFN-y) (22) , which up regulates Fc receptor expression on monocytes (12) and further increases infection by immune enhancement (19) . In addition, we have recently detected serotype-cross-reactive, CD4+ CD8-cytotoxic Tlymphocyte (CTL) clones, which are class II restricted and secrete IFN-y (22a) .
It is also important to identify dengue virus-specific, CD8+, class I-restricted CTL and to define their functions.
Evidence from studies in virus-infected animals indicates a necessary role for CD8+ virus-specific CTL in recovery from certain virus infections (6, 23) and for inducing immunopathology (9, 23) .
Little is known about CD8+ cells in dengue virus infections. They do not seem to proliferate in response to soluble dengue virus antigens (27) , and dengue virus-specific, CD8+ CTL have not yet been described. However, T-cell responses to soluble antigens are usually of the CD4+ variety (7, 18, 20, 24) , probably because of the class II-restricted nature of soluble antigen processing. CD8+ CTL responses have been detected to other viruses after stimulation with live virus (2) or with virus-infected fibroblasts (16) . This is * Corresponding author. presumably due to a requirement for intracellular antigen processing, which appears to be important for optimal antigen presentation in the context of class I molecules (17, 26, 33) .
In (8) and which was used as a control; and E, which contains the gene for dengue virus type 4 E protein (4) .
Preparation of dengue virus antigens. Dengue virus antigens were prepared as described previously (22) Antigen pulsation was performed after seeding 105 LCL or fibroblasts in 24-well cluster plates in a volume of 0.5 ml.
Soluble dengue virus antigens were added at final dilutions between 1:20 and 1:200 15 to 18 h before cytotoxicity assays. In some experiments, beta interferon (Lee Biomolecular, San Diego, Calif.) was added at a final concentration of 5,000 U/ml 2 to 3 days before antigen pulsation. This has been shown to render target cells resistant to lysis by NK cells (31) and to increase their sensitivity to CTL (5) .
Cell surface antigen analysis. Anti-Leu2 (CD8) and antiLeu3 (CD4) antibodies directly conjugated to fluorescein isothiocyanate (Becton Dickinson Co., Mountain View, Calif.) were used to quantitate CD8+ and CD4+ PBMC. Briefly, 20 ,u1 of antibody was mixed with 105 to 106 cells in a volume of 50 ,ul and incubated for 45 to 60 min at 4°C. Cells were then washed twice in cold RPMI 1640 and were then analyzed on a fluorescence-activated cell sorter (FACS 440; Becton Dickinson Co.) or by fluorescence microscopy.
Antibody-complement depletion. Anti-OKT4 (CD4) and anti-OKT8 (CD8) antibodies (Ortho Diagnostic Systems, Inc., Raritan, N.J.) and anti-Leu llb (CD16; Becton Dickinson Co.) were used in antibody-complement depletion experiments. A total of 1 x 106 to 2 x 106 virus-stimulated PBMC were suspended in 50 ,ul, and then 100 ,l1 of antibody diluted 1:15 was added, followed by incubation at 4°C for 30 min. The cells were washed twice in cold RPMI 1640 and suspended in 100 Pld, to which 200 ,lI of rabbit complement diluted 1:3 (Cedarlane Laboratories, Ontario, Canada) was added, followed by incubation for 1 h at 37°C. Cells were then washed three times in RPMI 1640 and were used in cytotoxicity assays.
Cytotoxicity assays. 
RESULTS
Stimulation of dengue virus type 4-immune PBMC with live or UV-inactivated dengue virus. PBMC taken from a dengue virus type 4-immune donor were placed in culture with either live dengue virus or virus which had been exposed to UV light and shown to have no plaque-forming capacity. After 6 days, the cells were pulsed with [3H]thymidine, and proliferation was assessed. The results in Table 1 show that the dengue virus type 4-immune PBMC responded best to dengue virus type 4. There was also a lower but significant response to dengue virus type 2, which indicated that the response was serotype cross-reactive. Nonimmune PBMC did not respond (data not shown), and UV-inactivated dengue virus type 4 failed to generate a response.
Lysis of dengue virus-infected fibroblasts by dengue virus type 4-immune PBMC stimulated by live dengue virus. PBMC from a dengue virus type 4-immune donor were tested for cytotoxic activity against dengue virus-infected autologous fibroblasts after 7 to 9 days of stimulation with dengue virus. Fibroblasts were chosen as target cells to detect CD8+ CTL because they do not constitutively express class II major histocompatibility complex antigens (25) . Dengue virus type 4-immune PBMC stimulated with either dengue virus type 2 or dengue virus type 4 lysed fibroblasts infected with either serotype (Table 2 ). Uninfected cells were also lysed, but the levels of lysis were always lower than those against virusinfected targets. These results show that the cytotoxic response is serotype cross-reactive.
Characterization of cytotoxic activity. Antibody-blocking and antibody-complement depletion studies were carried out to determine the identity of the killer cells. Inclusion in the cytotoxicity assay of an antibody against class I antigens, W6/32, inhibited the killing of dengue virus type 2-infected (Table 3) . Anti-CD4 and complement treatment similarly killed 35% of the effector population but failed to inhibit the cytotoxic activity (Table 3) . Anti-Leu llb and complement treatment failed to induce either a significant decrease in viability (data not shown) or a reduction in the cytotoxic capacity of effector cells (Table  3) . Taken (Table 4) . Thus, these CTL are cross-reactive against all four dengue virus serotypes.
We characterized the major histocompatibility complex restriction of killing against LCL by including antibodies to class I (W6/32) and class II (OKIa-1) antigens in the cyto- toxicity assays. W6/32 inhibited the killing by 57%, whereas OKIa-1 had no effect. These data and the fact that fibroblasts, which lack class II antigens, are killed argue strongly that this lysis is mediated by class I-restricted CTL.
Lysis of fibroblasts infected with dengue virus-vaccinia virus recombinants. We examined the proteins which are targets for dengue virus-specific class I-restricted CTL by infecting fibroblasts with dengue virus-vaccinia virus recombinant viruses, each of which contained a different portion of the dengue virus type 4 genome. Recombinant A contained genes which code for dengue virus proteins NS1, NS2a, NS2b, NS3, NS4a, and 84% of NS4b. Recombinant B contained genes coding for C, pre-M, E, NS1, and NS2a. Recombinant C included genes coding for NS1 and NS2a, and recombinant E contained genes coding for the E protein.
Recombinant D is the parental vaccinia virus which contains the lacZ gene and has none of the dengue virus genome and served as a control. CTL lysed fibroblasts infected with recombinants A, B, and E, but not those infected with C and D (Table 5 ). These results show that E is a target protein for these CTL but that NS1 and NS2a are not. The data also imply that at least one of the NS2b, NS3, NS4a, or NS4b proteins is a target for these CTL. From these studies, we cannot determine whether C, pre-M, and NS5 contain target epitopes for CTL. Recombinant vaccinia viruses which contained the genes for the dengue virus type 2C, pre-M, and E proteins and the genes for dengue virus type 2 NS1 and NS2a proteins were also used to infect autologous fibroblasts. Consistent with the concept that these CTL are cross-reactive, fibroblasts infected with the dengue virus type 2 recombinant expressing C, pre-M, and E proteins were lysed by dengue virus type 4-stimulated, dengue virus type 4-immune PBMC. However, these PBMC did not lyse fibroblasts infected with the dengue virus type 2 recombinant expressing NS1 and NS2a (data not shown).
DISCUSSION
In this report, we describe serotype-cross-reactive, CD8+ CD4-, class I-restricted, dengue virus-specific CTL obtained after stimulation with live virus of PBMC from a dengue virus-immune individual. The evidence that lysis was mediated by class I-restricted CD8+ CTL is as follows: (i) antibody and complement treatment of the effectors using anti-CD8 or anti-CD3 but not anti-CD16 or anti-CD4 depleted the killing (Table 3) ; (ii) antibody to class I but not class II antigens decreased the level of lysis (Table 3) ; (iii) virus-infected fibroblasts, which do not express major histocompatibility complex class II antigens (25) , were specifically lysed (Tables 2, 4 , and 5). In other viral systems (2, 16) , the use of live virus or virus-infected fibroblasts has also been necessary to induce class I-restricted CD8+ CTL. This may be due to the requirement for intracellular antigen synthesis sometimes required for optimal presentation of antigen in the context of class I molecules (17, 26, 33) . Stimulation of PBMC with soluble dengue virus antigens generated CD4+ class II-restricted CTL (22a). We failed to induce CD8+ CTL with soluble dengue virus antigens despite inducing good levels of proliferation.
However, fibroblasts and LCL pulsed with these antigens were sensitive to class I-restricted CTL-mediated lysis. This appears to be consistent with a report which showed that influenza virus proteins could bind to class I antigens displayed on the plasma membrane and that these antigenpulsed targets were sensitive to lysis by influenza virusspecific, CD8+, class I-restricted CTL (32) .
A (4) . Cell-mediated immune responses were not analyzed in those experiments, and the mechanism of protection remains speculative.
Further studies are needed to better define the proteins and epitopes which are recognized by dengue virus-specific CTL and their major histocompatibility complex haplotype restrictions. This information could be important in determining which elements of the CTL response contribute to recovery from dengue virus infection and to the severe complications of dengue virus infections.
